1. Home
  2. NUTX vs JANX Comparison

NUTX vs JANX Comparison

Compare NUTX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

N/A

Current Price

$191.49

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$16.21

Market Cap

975.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUTX
JANX
Founded
2011
2017
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
975.7M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NUTX
JANX
Price
$191.49
$16.21
Analyst Decision
Strong Buy
Buy
Analyst Count
2
13
Target Price
$252.50
$47.00
AVG Volume (30 Days)
120.9K
667.0K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
15.87
N/A
Revenue
$875,257,000.00
$10,000,000.00
Revenue This Year
$6.12
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
$11.87
N/A
Revenue Growth
82.36
N/A
52 Week Low
$77.21
$12.12
52 Week High
$204.00
$35.34

Technical Indicators

Market Signals
Indicator
NUTX
JANX
Relative Strength Index (RSI) 60.19 55.96
Support Level $146.07 $13.13
Resistance Level $195.52 $16.68
Average True Range (ATR) 13.84 0.60
MACD 3.57 0.02
Stochastic Oscillator 79.05 75.39

Price Performance

Historical Comparison
NUTX
JANX

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: